StocksMedium•11 November 2026•
1 min read
Medexus Reports Record $29.1 Million Revenue in Fiscal Q2 2027
Key Facts
1Medexus achieved net revenue of $29.1 million in the fiscal second quarter ended September 30, 2026.
2The company recorded net income of $0.8 million and operating income of $2.4 million, marking quarterly records since fiscal 2025.
3The product GRAFAPEX (treosulfan) contributed record product-level net revenue of $5.7 million during the quarter.
Medexus achieved net revenue of $29.1 million in the fiscal second quarter ended September 30, 2026. Newsfile Corp reported that the company recorded net income of $0.8 million and operating income of $2.4 million, marking the highest quarterly records for the firm since fiscal 2025.
The product GRAFAPEX, also known as treosulfan, bolstered these results by contributing record product-level net revenue of $5.7 million during the quarter. Medexus Pharmaceuticals also saw its Adjusted EBITDA reach $5.1 million, reflecting continued positive operational performance for the company.